Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Everyday memory impairment, neuroradiological findings and physical disability in multiple sclerosis.
Step-rate thresholds for physical activity intensity in persons with multiple sclerosis.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
[Pay attention to the related advances of demyelinating diseases in the central nervous system].
Novel Therapeutic Approach by Nicotine in Experimental Model of Multiple Sclerosis.
Comparison of Routine Brain Imaging at 3 T and 7 T.
The Volume Activated Potassium Channel KCNK5 is Up-Regulated in Activated Human T Cells, but Volume Regulation is Impaired.
Interferon-beta exposure during first trimester is safe in women with multiple sclerosis-A prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Application of multispectral imaging detects areas with neuronal myelin loss, without tissue labelling.
Neuroprotective Effects of Transplanted Mesenchymal Stromal Cells-derived Human Umbilical Cord Blood Neural Progenitor Cells in EAE.
Physical and social environment and the risk of multiple sclerosis.
Redox-based regulation of neural stem cell function and Nrf2.
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
NMDA receptor antibodies associated with distinct white matter syndromes.
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
Seroprevalence of NMO-IgG Antibody in Neuromyelitis optica (NMO) and Its Specificity in Differentiating NMO from Other Demyelinating Diseases with Overlap Symptoms: An Iranian Experience.
Can we measure long-term treatment effects in multiple sclerosis?
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions.
Pages
« first
‹ previous
…
425
426
427
428
429
430
431
432
433
…
next ›
last »